Premium
Prevalencia de Malaria y tratamiento de pacientes febriles en instalaciones sanitarias y minoristas de medicamentos en Camerún
Author(s) -
Mangham Lindsay J.,
Cundill Bonnie,
Achonduh Olivia A.,
Ambebila Joel N.,
Lele Albertine K.,
Metoh Theresia N.,
Ndive Sarah N.,
Ndong Ignatius C.,
Nguela Rachel L.,
Nji Akindeh M.,
OrangOjong Barnabas,
Wiseman Virginia,
PamenNgako Joelle,
Mbacham Wilfred F.
Publication year - 2012
Publication title -
tropical medicine and international health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.056
H-Index - 114
eISSN - 1365-3156
pISSN - 1360-2276
DOI - 10.1111/j.1365-3156.2011.02918.x
Subject(s) - malaria , medicine , artemisinin , health facility , public health , odds ratio , cross sectional study , odds , environmental health , family medicine , population , plasmodium falciparum , health services , logistic regression , immunology , nursing , pathology
Objective To investigate the quality of malaria case management in Cameroon 5 years after the adoption of artemisinin‐based combination therapy (ACT). Treatment patterns were examined in different types of facility, and the factors associated with being prescribed or receiving an ACT were investigated. Methods A cross‐sectional cluster survey was conducted among individuals of all ages who left public and private health facilities and medicine retailers in Cameroon and who reported seeking treatment for a fever. Prevalence of malaria was determined by rapid diagnostic tests (RDTs) in consenting patients attending the facilities and medicine retailers. Results Among the patients, 73% were prescribed or received an antimalarial, and 51% were prescribed or received an ACT. Treatment provided to patients significantly differed by type of facility: 65% of patients at public facilities, 55% of patients at private facilities and 45% of patients at medicine retailers were prescribed or received an ACT ( P = 0.023). The odds of a febrile patient being prescribed or receiving an ACT were significantly higher for patients who asked for an ACT (OR = 24.1, P < 0.001), were examined by the health worker (OR = 1.88, P = 0.021), had not previously sought an antimalarial for the illness (OR = 2.29, P = 0.001) and sought treatment at a public (OR = 3.55) or private facility (OR = 1.99, P = 0.003). Malaria was confirmed in 29% of patients and 70% of patients with a negative result were prescribed or received an antimalarial. Conclusions Malaria case management could be improved. Symptomatic diagnosis is inefficient because two‐thirds of febrile patients do not have malaria. Government plans to extend malaria testing should promote rational use of ACT; though, the introduction of rapid diagnostic testing needs to be accompanied by updated clinical guidelines that provide clear guidance for the treatment of patients with negative test results.